Search

everythinglearnresearchcommunity

for

Search:↓

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

PCOS requires personalized treatment to improve life quality and reduce health risks.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Saw palmetto helps with nighttime urination and urine flow, similar to finasteride.

New treatments for hair loss are being developed using molecular biology.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Nanotechnology shows promise for better hair loss treatments but needs more research for safety and effectiveness.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

A new compound effectively inhibits human 5α-reductase 1.

Finasteride and minoxidil work best together for hair loss.

Certain drugs that block specific enzymes can help treat prostate diseases.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.